Determining doses for backfill cohorts based on patient-reported outcome
Determining doses for backfill cohorts based on patient-reported outcome
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Incorporating backfill cohorts in phase I oncology trials is a recently developed strategy for dose optimization. However, the efficacy assessment window is long in general, causing a lag in identifying ineffective doses and more patients being backfilled to those doses. There is necessity to investigate how to use patient-reported outcomes (PRO) t...
Alternative Titles
Full title
Determining doses for backfill cohorts based on patient-reported outcome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_62f600a0f0104a43b2cc305a31edbf70
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62f600a0f0104a43b2cc305a31edbf70
Other Identifiers
ISSN
1471-2288
E-ISSN
1471-2288
DOI
10.1186/s12874-024-02398-w
